Summary.-The growth pattern and morphology of two transplantable acute leukaemias which arose spontaneously in pure line rats are described. They differ morphologically and on the basis of their behaviour in vivo, such as infiltration of lymphoid organs and presence in thoracic duct lymph, the leukaemia syngeneic to the August strain (referred to as the SAL) appears to be of myeloid type whereas the leukaemia syngeneic to the Hooded strain (referred to as the HRL) resembles acute lymphoblastic leukaemia. The HRL cells, but not the SAL cells, are lysed by murine anti-O serum plus complement. These two transplantable acute leukaemias appear to be useful animal counterparts to the human acute leukaemias and may be valuable models for studies on chemotherapy and immunotherapy.
SPONTANEOUSLY occurring leukaemias are uncommon in rats (Moloney, Boschetti and King, 1969; Moloney, 1974) and carcinogens which readily produce leukaemias in mice are less effective in rats (Moloney, Boschetti and Dowd, 1965) . This paper describes 2 rat leukaemias, one of a " myeloid " type and the other of a " lymphoid " type, which arose spontaneously in an August and Hooded rat respectively. Syngeneic transplants of these tumours may constitute realistic models of human acute leukaemias.
MATERIALS AND METHODS
Origins of the leukaemias.-The Sutton August leukaemia (SAL) arose spontaneously in 1966 in a normal female August rat and has been maintained by serial transplantation through syngeneic rats. In 1970 a stock of frozen cells from a specific passage was laid down in liquid nitrogen. The Hooded rat leukaemia (HRL) arose in a normal male Hooded rat in 1971. It has been maintained by serial transplantation in Hooded rats, and cells from the original donor rat have been stored in liquid nitrogen. As the number of transplant generations increased, and the average duration of the disease decreased to 15-18 days, these pathological observations became less apparent. The peripheral blood count at death varied between 500,000 and 1,000,000/mm3 in all transplant generations and more than 9500 of the cells were leukaemic blasts. The haemoglobin at death was in the range of 9-12 g/ 100 ml blood and the platelet count was 50,000-80,000/mm3. Bone marrow infiltration was observed but occurred later in the disease when compared with the SAL, although at death the marrow was almost totally replaced by lymphoblasts.
Animals-Inbred
Morphology and susceptibility to rinurine anti-9 8erum SAL. SAL leukaemia cells were variable in size (15-30 ,m diameter) but remarkably uniform for a myelogenous leukaemia when compared with human acute myeloid leukaemia. The cytoplasm was abundant, basophilic and agranular. The nuclei were large, irregular and often cleft with ill-defined nucleoli. Electron micrographs of SAL cells (Fig. 1) SAL cells proliferated initially mainly in the bone marrow. At 4-6 days blasts could be detected in the spleen and peripheral blood and on subsequent days the peripheral blood white cell count started to rise, with a concomitant increase in the blast count. There was a total increase of only 1 g in the wet weight of the liver but 1-1.5 g increase in the spleen representing a three-fold increase over the initial value: the increase in weight in both cases took place from Days 6-8. By Day 7-8 other organs became involved and in addition to extensive infiltration of the red pulp of the spleen some leukaemic blasts could be seen in the thymus and in the sinusoids of the lymph nodes, suggesting that there was no true colonization of these organs. This was supported by the observation that when the peripheral blood count was 90-300,000/mm3 only a small percentage of blasts could be found in the thoracic duct lymph. Liver involvement was confined to the sinusoids and a few leukaemic blasts could be seen in the glomerular medullary capillaries of the kidney and alveolar capillaries of the lung.
The early passages of the HRL contrasted with the SAL in that leukaemia cells proliferated initially in the spleen and not the bone marrow. Blasts became detectable in the peripheral blood at Day 7, after which there was a sharp increase up to 14-16 days when a final plateaut was reached. Blasts became identifiable in the lymph nodes and bone marrow at 9-10 days and the number of platelets began to increase at 12-14 days. Spleen weight remained constant until Day 8, then increased rapidly until a value of 6 times the normal value was reached. The liver showed only a 1% increase in weight during the same period. The growth of HRL cells in Hooded rats in later passages (from passage 8-9) showed a striking change. Survival time was decreased by about 7 days. Leukaemic cells proliferated in the bone marrow and not the spleen; blasts become detectable at 5 days and at the same time being identified in the peripheral blood. Here the number of blasts rose slowly until the eighth day when it increased very rapidly so that during the next few days blasts accounted for nearly all the white cells in the blood. As the HRL blasts began to accumulate rapidly in the peripheral blood they became detectable in the spleen where invasion was rapid and caused a seven-fold increase in spleen weight. Lymph node involvement was a comparatively late event and not very extensive. In the later passages blasts in the lymph nodes first became detectable between 10 and 12 days. In contrast to the SAL 40%0 leukaemic blasts could be Hoo(ledl rats (for rats cannulated when the peripheral blood count was 100,000/mm3. The level of blasts in the thoracic duct was similar in all transplant generations. Involvement of most organs occurred and was similar in pattern in all passages but was less extensive in the later ones. The normal architecture of the spleen, lymph nodes and thymus was destroyed and tumour masses could be seen in the liver surrounding the periportal tracts and in the sinusoids, as well as in the medullary and glomerular capillaries of the kidney and in the peribronchial and perivascular areas of the lung. In early passages involvement of the CNS was extensive; the spinal cord, brain, peripheral nerves and the musculature vertebral column were tumour cells. surrouniding the all infiltrated by DISCUSSION SAL and HRL leukaemias cannot be clearly classified by morphological criteria alone, but functionally SAL can be considered to be a " myeloid" leukaemia because (1) bone marrow colonization occurs early in the disease with lymphoid involvement being apparently of a secondary nature; (2) the lymph nodes themselves were not extensively infiltrated and the lymphoid follicles remained intact; (3) the spleen, although heavily involved, showed proliferation primarily in the red pulp and not in the Malpighian corpuscles; (4) even when a high percentage of blasts were present in the peripheral blood very few of these could be detected in the thoracic duct lymph; (5) the cells were not lysed by a murine anti-O serum.
The lymphoid character of the HRL leukaemia is indicated (1) by extensive involvement especially in early transplant generations of lymphoid organs, including the thymus; (2) destruction of the lymphoid follicles in the lymph nodes; (3) invasion of the white pulp of the spleen; (4) the presence of high numbers of blasts in the thoracic duct lymph; (5) susceptibility to lysis by murine anti-O serum and complement. In early transplant generations bone marrow colonization was a late event but occurred progressively earlier with subsequent transplantation and in this respect the pattern of growth of the HRL became more like that of SAL.
Both diseases are acute in nature and are in several respects comparable to acute myeloblastic leukaemia (AML) and acute lymphoblastic leukaemia (ALL) in man.
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